GERON
Geron Corp. operates as a biopharmaceutical company which discovers and develops therapeutic products for cancer. Imetelstat, a novel, first-in-class telomerase inhibitor, is a product candidate in clinical development.
GERON
Social Links:
Industry:
Biopharma Biotechnology Health Diagnostics Pharmaceutical
Founded:
1990-08-28
Address:
Menlo Park, California, United States
Country:
United States
Website Url:
http://www.geron.com
Total Employee:
101+
Status:
Active
Contact:
6504737718
Email Addresses:
[email protected]
Total Funding:
361.7 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Content Delivery Network Google Universal Analytics Apache Microsoft Exchange Online
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Novavax
Novavax is a clinical-stage biotechnology company focused on the discovery and development of innovative vaccines.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Hercules Capital
Hercules Capital investment in Post-IPO Debt - Geron
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Debt - Geron
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - Geron
Venrock
Venrock investment in Seed Round - Geron
Key Employee Changes
Official Site Inspections
http://www.geron.com Semrush global rank: 397.72 K Semrush visits lastest month: 140.19 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Geron"
Geron Corporation - Wikipedia
Geron, based in Foster City, California, was founded by gerontologist Mary C. West and Michael D. West, now CEO of AgeX Therapeutics. [2] [3] They secured initial venture capital …See details»
Geron Corporation - Investors & Media
Apr 18, 2025 Geron is a commercial-stage biopharmaceutical company with a first-in-class telomerase inhibitor that is approved in the United States for the treatment of certain adult …See details»
Geron
Scientific study of aging: The Gerontological Society of America (GSA) is a leading, forward-thinking interdisciplinary organization devoted to research, education, advocacy and practice …See details»
Geron - Crunchbase Company Profile & Funding
Geron is a biotechnology company that specializes in developing blood cancer treatments for hematologic malignancies. The company's Imetelstat, an …See details»
Geron Associates Limited
Geron + Windsor Tunnel. Duty Free Redesign Strategy . View Case Study. Want to see more of our work? View all Projects. Niche Capabilities. PRESENTATION CENTRES. We specialize in creating high-end presentation centres for home …See details»
Geron - The Org
Geron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic …See details»
Geron Org Chart + Executive Team - The Official Board
The organizational chart of Geron displays its 23 main executives including Dawn Carter Bir, Michelle Robertson, Andrew Grethlein and Patrick Murphy. Toggle navigation The Official …See details»
Geron: Contact Details, Revenue, Funding, Employees and …
Geron is a commercial-stage biopharmaceutical company focused on blood cancer treatment. Their FDA-approved telomerase inhibitor targets low-to-intermediate-risk myelodysplastic …See details»
Our tireless pursuit - Geron
Geron (the “Company”) recognizes the value of each individual and is committed to providing equal employment and advancement opportunities. In accordance with applicable law, we prohibit discrimination against any applicant or …See details»
Geron Corporation - Geron Corporation Reports First Quarter 2025 ...
May 7, 2025 FOSTER CITY, Calif.--(BUSINESS WIRE)-- Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course …See details»
Our story continues to evolve - Geron
For more than 30 years, Geron has tirelessly dedicated itself to the pursuit of new therapies for patients with blood cancers ... Elizabeth H. Blackburn – Facts (nobelprize.org). Accessed …See details»
Geron Corporation Announces Departure of Chief Executive Officer
Mar 11, 2025 Geron is a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer. Our first-in-class telomerase inhibitor RYTELO™ …See details»
Leadership Team - Team at Geron - The Org
Geron's Leadership Team includes Olivia K. Bloom and 7 others. Edit team. Team members. Andrew J. Grethlein EVP & COO. Anil Kapur EVP, Corporate Strategy & Chief Commercial …See details»
Geron Corporation Reports First Quarter 2025 Financial Results …
FOSTER CITY, Calif., May 07, 2025--Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, …See details»
Our leadership team - Geron
Our leadership. With a seasoned leadership team with world-class expertise spanning research, clinical development, regulatory, manufacturing and commercial experience in hematologic …See details»
Geron Corporation - Investors & Media - Corporate Governance
Stockholders wishing to contact Geron’s Board of Directors, may do so by writing c/o Secretary, Geron Corporation, 919 E. Hillsdale, Suite 250, Foster City, CA 94404, or via email to …See details»
Geron Corporation Announces Departure of Chief Executive Officer
Mar 11, 2025 Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced …See details»
Our culture sets us apart - Geron
At Geron, our innovative and collaborative culture has been foundational to advancing our mission to change lives by changing the course of blood cancer. Our vision can only be accomplished …See details»
Our commitment to patients | Geron
Geron (the “Company”) recognizes the value of each individual and is committed to providing equal employment and advancement opportunities. In accordance with applicable law, we …See details»
Careers - Geron
Geron endeavors to make www.geron.com accessible to any and all users. If you would like to contact us regarding the accessibility of our website or need assistance completing the …See details»